Could a daily supplement help kids with obesity shed fat?

NCT ID NCT06309121

Ongoing Disease control Sponsor: Fundació Sant Joan de Déu Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a postbiotic supplement called ABB C3 in 70 children and teens with obesity. Half take the supplement and half take a placebo for 3 months, with an optional 3-month extension for all. Researchers will measure changes in body fat and blood sugar levels to see if the supplement is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Postbiotic blend ABB C3 (dietary supplement)
What this could lead to: If it works, this could offer a safe, natural way to help children with obesity reduce body fat and improve metabolic health.
What could go wrong: This is an early-stage trial with only 70 participants, so results may not apply to everyone. The supplement may cause mild stomach issues and might not lead to lasting weight loss.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY, ADOLESCENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY, ADOLESCENT OBESITY, CHILDHOOD

Contacts and locations

Locations

Hospital Sant Joan de Déu

Barcelona, Barcelona, 08950, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.